Skip to Content
Morningstar
Get 14 Days Free

Ventas Inc VTR

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Ventas Reports Same-Store NOI Below Our Expectations for Each Segment, Leading to Q2 Miss

Kevin Brown Equity Analyst

Analyst Note

| Kevin Brown |

No-moat Ventas reported disappointing second-quarter results, though we didn't see anything that would materially affect our $64 fair value estimate. Senior housing same-store occupancy improved 110 basis points sequentially to 77.5%, which is slightly below our 78.3% estimate for the quarter. With lower occupancy, Ventas wasn't able to improve rate growth like we had expected, with the reported figure falling 2.7% compared with our estimate of 0.6% growth. As a result, same-store revenue for the senior housing portfolio fell 7.9% year over year, though that was better than the declines reported the prior four quarters. 

Read Full Analysis

Company Profile

Business Description

Ventas owns a diversified healthcare portfolio of 1,200 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of NOI.

Contact
353 North Clark Street, Suite 3300
Chicago, IL, 60654
T +1 877 483-6827
Sector Real Estate
Industry REIT - Healthcare Facilities
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type Hard Assets
Employees 448

Related

Our Picks
13 Stocks You Think You Should Sell But Shouldn't
These stocks carry sky-high price/earnings ratios, but we think they're actually undervalued.
Susan Dziubinski
Our Picks
33 Undervalued Stocks for the Third Quarter
Here are our analysts' top ideas in each sector for the coming quarter.
Susan Dziubinski
Quarter-End Insights
Hard-Hit Real Estate Subsectors Picking Up Steam
With vaccine rollout, shoppers are back in the stores and travelers are returning to hotels.
Kevin Brown
Our Picks
33 Undervalued Stocks for the Second Quarter
Here are our analysts' top ideas in each sector for the coming quarter.
Susan Dziubinski
Quarter-End Insights
Vaccine Rollout a Big Boost for Hotels and Retail Real Estate
Sector trades at a 4% premium to our fair value estimates.
Kevin Brown
US Videos
3 Real Estate Stocks for Dividend Seekers
A pullback in the sector has led to opportunity for income investors.
Morningstar
Our Picks
33 Undervalued Stocks for 2021
Here are our analysts' top ideas in each sector for the new year.
Susan Dziubinski
Quarter-End Insights
We Expect Malls and Hotels to Rebound
We believe most REITs will continue to pay dividends, making their increased yields attractive to investors.
Kevin Brown
Our Picks
33 Undervalued Stocks for the Fourth Quarter
Here are our analysts' top ideas in each sector.
Susan Dziubinski
Quarter-End Insights
Lots of Opportunities in Yield-Rich Real Estate Sector
A fourth of the real estate sector trades in 5-star territory.
Kevin Brown
Our Picks
33 Undervalued Stocks
Here are our analysts' top ideas in each sector this quarter.
Susan Dziubinski
Quarter-End Insights
Good Value Can Be Found Among Hard-Hit Real Estate Subsectors
We expect malls, hotels, and healthcare subsectors to rebound.
Kevin Brown
Quarter-End Insights
Best Values Among Hardest-Hit Real Estate Subsectors
Hotel, mall, and healthcare subsectors should rebound strongly once the global crisis is over.
Kevin Brown
US Videos
Dividend Opportunities in Real Estate Sector
Income-oriented investors should keep an eye on Macerich, Park Hotels & Resorts, and Ventas.
Kevin Brown
US Videos
3 REITS Providing Above-Average Dividends
Investors should keep an eye out for high dividend payouts and potential capital gains in these real estate opportunities.
Kevin Brown
US Videos
Top REITs for Yield Seekers
Income-oriented investors should keep an eye on these healthcare and retail REIT firms.
Kevin Brown
Stock Strategist Industry Reports
Look Past Near Term for Healthcare REITs' Value
We see long-term tailwinds and attractive dividend yields.
Kevin Brown
US Videos
2 Undervalued Healthcare REITs
Ventas and Welltower hold Exemplary stewardship ratings that we believe will create value.
Kevin Brown
Quarter-End Insights
Real Estate: Through the Noise, Opportunities Exist
To navigate the choppy waters ahead, keep it simple and focus on the fundamentals.
Edward Mui
Stock Strategist Industry Reports
REITs at Their Peaks?
Long in the tooth, the current real estate cycle keeps going.
Edward Mui

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.